HULL ANDREW bought INM
December 19, 2025 · Form 4 insider transaction
HULL ANDREW bought 1,750 shares of InMed Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,750
Price
$0.00
Total value
N/A
InsiderHULL ANDREW
Role—
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 19, 2025
Filing dateDecember 19, 2025
Shares owned after2,711
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted on 12/19/2025 and will vest 100% on the one-year anniversary of the grant date (December 18, 2026) or immediately prior to the next Annual General Meeting, whichever is sooner.